Browner M F, Smith W W, Castelhano A L
Molecular Structure Department, Syntex Discovery Research, Palo Alto, California 94303, USA.
Biochemistry. 1995 May 23;34(20):6602-10. doi: 10.1021/bi00020a004.
Matrix metalloproteases are a family of enzymes that play critical roles in the physiological and pathological degradation of the extracellular matrix. These enzymes may be important therapeutic targets for the treatment of various diseases where tissue degradation is part of the pathology, such as cancer and arthritis. Matrilysin is the smallest member of this family of enzymes, all of which require zinc for catalytic activity. The first X-ray crystal structures of human matrilysin are presented. Inhibitors of metalloproteases are often characterized by the chemical group that interacts with the active site zinc of the protein. The structures of matrilysin complexed with hydroxamate (maximum resolution 1.9 A), carboxylate (maximum resolution 2.4 A), and sulfodiimine (maximum resolution 2.3 A) inhibitors are presented here and provide detailed information about how each functional group interacts with the catalytic zinc. Only the zinc-coordination group is variable in this series of inhibitors. Examination of these inhibitor-matrilysin complexes emphasizes the dominant role the zinc-coordinating group plays in determining the relative potencies of the inhibitors. The structures of these matrilysin-inhibitor complexes also provide a basis for comparing the catalytic mechanism of MMPs and other metalloproteins.
基质金属蛋白酶是一类在细胞外基质的生理和病理降解过程中发挥关键作用的酶。这些酶可能是治疗各种疾病的重要治疗靶点,在这些疾病中,组织降解是病理过程的一部分,如癌症和关节炎。基质溶素是该酶家族中最小的成员,所有这些酶的催化活性都需要锌。本文展示了人基质溶素的首批X射线晶体结构。金属蛋白酶抑制剂通常以与蛋白质活性位点锌相互作用的化学基团为特征。本文展示了与异羟肟酸酯(最高分辨率1.9埃)、羧酸盐(最高分辨率2.4埃)和磺二亚胺(最高分辨率2.3埃)抑制剂复合的基质溶素结构,并提供了有关每个官能团如何与催化锌相互作用的详细信息。在这一系列抑制剂中,只有锌配位基团是可变的。对这些抑制剂 - 基质溶素复合物的研究强调了锌配位基团在确定抑制剂相对效力方面所起的主导作用。这些基质溶素 - 抑制剂复合物的结构也为比较基质金属蛋白酶和其他金属蛋白的催化机制提供了基础。